SMTL ID : 9cur.1

BmrCD in the inward-facing conformation bound to Hoechsts and lipids

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-mer

Ligands

27 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)

POV.1: 11 residues within 4Å: Chain A: Y.14, K.16, L.17, T.20, L.23, L.24, L.173, M.176, R.180 Ligands: POV.6, POV.18 Ligand excluded by PLIP POV.2: 16 residues within 4Å: Chain A: T.26, V.29, G.30, L.33, T.34, F.37, I.38, K.41, L.155, I.236, F.239, G.240, T.243, A.244, L.247, Y.378 Ligand excluded by PLIP POV.3: 7 residues within 4Å: Chain A: K.251, V.255, C.351, W.354, H.355, G.358, A.359 Ligand excluded by PLIP POV.4: 8 residues within 4Å: Chain A: K.2, I.3, G.4, L.7, L.396, R.400 Ligands: POV.12, POV.13 Ligand excluded by PLIP POV.5: 15 residues within 4Å: Chain A: I.262, L.265, W.266, I.269, Y.273, Y.277, R.328, L.335, M.336, L.340, V.343, I.344 Chain B: Y.94 Ligands: POV.11, POV.25 Ligand excluded by PLIP POV.6: 12 residues within 4Å: Chain A: V.164, F.165, Y.168, G.169, Y.172 Chain B: K.259, F.262, L.266, P.269, T.270, L.273 Ligands: POV.1 Ligand excluded by PLIP POV.7: 16 residues within 4Å: Chain A: F.231, S.234, G.235, M.238, V.260, I.263, W.264, S.267, V.268, R.271, I.389, F.393, L.396 Ligands: POV.10, POV.11, POV.12 Ligand excluded by PLIP POV.8: 14 residues within 4Å: Chain A: L.7, W.8, A.11, L.12, R.15, L.18, I.19, V.22, L.23, Y.224, V.227, L.228, V.232 Ligands: POV.13 Ligand excluded by PLIP POV.9: 8 residues within 4Å: Chain A: I.146, V.150, I.153, C.154, G.157 Chain B: L.280, F.288 Ligands: POV.22 Ligand excluded by PLIP POV.10: 13 residues within 4Å: Chain A: G.235, I.236, M.238, F.239, F.242, T.243, F.246, L.247, V.250, F.254, L.257, V.260 Ligands: POV.7 Ligand excluded by PLIP POV.11: 5 residues within 4Å: Chain A: R.272, Y.273 Ligands: POV.5, POV.7, POV.12 Ligand excluded by PLIP POV.12: 7 residues within 4Å: Chain A: V.268, R.271, F.393, E.397 Ligands: POV.4, POV.7, POV.11 Ligand excluded by PLIP POV.13: 6 residues within 4Å: Chain A: G.4, K.5, L.7, W.8 Ligands: POV.4, POV.8 Ligand excluded by PLIP POV.18: 7 residues within 4Å: Chain A: Y.172, M.176, R.180 Chain B: Y.254, Q.255, M.258 Ligands: POV.1 Ligand excluded by PLIP POV.19: 6 residues within 4Å: Chain B: L.200, Y.201, K.204, R.208, F.262, I.263 Ligand excluded by PLIP POV.20: 9 residues within 4Å: Chain B: S.199, G.202, S.203, H.206, I.321, N.322, Q.325 Ligands: POV.28, POV.31 Ligand excluded by PLIP POV.21: 8 residues within 4Å: Chain B: A.36, Y.37, W.38, L.39, R.40, I.43, Q.103 Ligands: POV.24 Ligand excluded by PLIP POV.22: 16 residues within 4Å: Chain A: I.153, G.157, L.160, V.161 Chain B: A.186, I.189, P.190, L.273, A.277, L.280, I.281, G.284, Y.285, F.288, R.292 Ligands: POV.9 Ligand excluded by PLIP POV.23: 8 residues within 4Å: Chain B: E.77, G.78, L.80, F.81, G.84, I.85, V.88 Ligands: POV.29 Ligand excluded by PLIP POV.24: 14 residues within 4Å: Chain A: F.323, Y.324, N.327 Chain B: I.43, L.47, A.92, I.95, M.96, Y.98, F.99, H.102, Q.103 Ligands: POV.21, POV.25 Ligand excluded by PLIP POV.25: 11 residues within 4Å: Chain A: N.327, R.328, L.330, N.331, L.335 Chain B: Y.94, I.95, Y.98, H.102 Ligands: POV.5, POV.24 Ligand excluded by PLIP POV.26: 14 residues within 4Å: Chain B: L.27, K.28, G.31, F.34, K.35, W.38, Y.41, I.45, L.49, I.158, L.161, V.162, T.165, M.166 Ligand excluded by PLIP POV.27: 10 residues within 4Å: Chain B: F.172, L.173, F.177, I.179, S.180, W.181, K.182, F.185, E.294, L.295 Ligand excluded by PLIP POV.28: 13 residues within 4Å: Chain B: M.168, F.172, I.188, L.191, P.192, A.195, I.196, S.199, M.310, M.314, I.317, I.321 Ligands: POV.20 Ligand excluded by PLIP POV.29: 16 residues within 4Å: Chain B: I.54, F.57, K.60, L.61, N.64, D.67, F.81, I.85, V.88, L.89, A.92, M.96, T.296, E.299 Ligands: POV.23, POV.30 Ligand excluded by PLIP POV.30: 14 residues within 4Å: Chain B: L.49, V.53, M.56, F.57, K.60, L.61, N.64, M.166, T.170, L.173, T.174, F.177, L.178 Ligands: POV.29 Ligand excluded by PLIP POV.31: 21 residues within 4Å: Chain A: H.171, Q.175, R.221, V.225, S.229 Chain B: I.198, G.202, S.203, I.205, H.206, F.209, T.210, Q.213, V.260, D.264, F.267, E.268, N.322, R.326 Ligands: HT1.16, POV.20 Ligand excluded by PLIP

2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.14: 16 residues within 4Å: Chain A: D.202, Y.439, Q.440, E.443, V.445, H.464, T.465, G.466, S.467, G.468, K.469, S.470, S.471, N.474, Y.480 Ligands: MG.17 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:D.202, A:Q.440, A:Q.440, A:E.443, A:G.466, A:S.467, A:G.468, A:K.469, A:S.470, A:Y.480 pi-Stacking: A:Y.439, A:Y.439 ATP.32: 14 residues within 4Å: Chain B: E.132, Y.368, S.371, N.375, K.394, T.395, G.396, S.397, G.398, K.399, T.400, T.401, Q.441, D.522 15 PLIP interactions: 15 interactions with chain B Hydrogen bonds: B:E.132, B:S.371, B:N.375, B:G.396, B:G.396, B:G.398, B:K.399, B:T.400, B:T.400, B:T.401, B:Q.441, B:Q.441, B:D.522 Salt bridges: B:K.399, B:K.399

2 x HT1: 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE(Non-covalent)

HT1.15: 17 residues within 4Å: Chain A: Q.326, H.338, V.341, N.342, R.345 Chain B: E.55, W.100, M.101, F.105, A.108, N.109, E.112, S.151, L.152, G.155, F.156, L.159 7 PLIP interactions: 4 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:F.105, B:A.108, B:F.156, A:H.338 Salt bridges: B:E.55 pi-Stacking: A:H.338, A:H.338 HT1.16: 16 residues within 4Å: Chain A: E.32, G.35, P.36, Y.156, L.160, R.381, Q.384 Chain B: K.272, V.275, G.276, Y.279, I.311, W.312, F.315, E.319 Ligands: POV.31 14 PLIP interactions: 4 interactions with chain A, 10 interactions with chain B Hydrophobic interactions: A:E.32, A:Y.156, B:K.272, B:V.275, B:Y.279, B:Y.279, B:I.311, B:W.312, B:F.315, B:F.315 Hydrogen bonds: A:Q.384, B:Y.279 pi-Cation interactions: A:R.381 Salt bridges: B:E.319

1 x MG: MAGNESIUM ION(Non-covalent)

MG.17: 5 residues within 4Å: Chain A: G.468, K.469, S.470, S.471 Ligands: ATP.14 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:S.470

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tang, Q. et al., Lipid-mediated mechanism of drug extrusion by a heterodimeric ABC exporter. Biorxiv (2025)

Release Date

2025-08-13

Peptides

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH: A
Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
C

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH

Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI

Related Entries With Identical Sequence